Nymox Pharmaceutical
NYMX
#7601
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-47.37%
Change (1 year)
Categories
EPS for Nymox Pharmaceutical (NYMX)
EPS in 2023 (TTM): -$0.06000
According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$0.06000. In 2022 the company made an earnings per share (EPS) of -$0.08000 an increase over its 2021 EPS that were of -$0.15.
EPS history for Nymox Pharmaceutical from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.06000 | -25% |
| 2022 | -$0.08000 | -46.67% |
| 2021 | -$0.15 | -11.76% |
| 2020 | -$0.17 | -15% |
| 2019 | -$0.20 | 5.26% |
| 2018 | -$0.19 | -26.92% |
| 2017 | -$0.26 | -7.14% |
| 2016 | -$0.28 | -40.43% |
| 2015 | -$0.47 | 291.67% |
| 2014 | -$0.12 | -7.69% |
| 2013 | -$0.13 | -43.48% |
| 2012 | -$0.23 | -25.81% |
| 2011 | -$0.31 | 55% |
| 2010 | -$0.20 | 25% |
| 2009 | -$0.16 | 0.08% |
| 2008 | -$0.16 | -11.12% |
| 2007 | -$0.18 | -0.16% |
| 2006 | -$0.18 | 28.59% |
| 2005 | -$0.14 | -12.49% |
| 2004 | -$0.16 | -16.05% |
| 2003 | -$0.19 | 19.07% |
| 2002 | -$0.16 | 14.45% |
| 2001 | -$0.14 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $4.97 | -8,386.55% | 🇺🇸 USA |
 Pfizer PFE | $3.82 | -6,466.67% | 🇺🇸 USA |
 Abbott Laboratories ABT | $3.29 | -5,591.17% | 🇺🇸 USA |
 Eli Lilly LLY | $7.10 | -11,932.15% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $6.97 | -11,716.67% | 🇺🇸 USA |